| 1 | EPCAM, HNPCC1
|
| Recurrence and variability of germline EPCAM deletions in Lynch syndrome.
|
| Kuiper RP, Vissers LE, Venkatachalam R, Bodmer D, Hoenselaar E, Goossens M, Haufe A, Kamping E, Niessen RC, Hogervorst FB, Gille JJ, Redeker B, Tops CM, van Gijn ME, van den Ouweland AM, Rahner N, Steinke V, Kahl P, Holinski-Feder E, Morak M, Kloor M, Stemmler S, Betz B, Hutter P, Bunyan DJ, Syngal S, Culver JO, Graham T, Chan TL, Nagtegaal ID, van Krieken JH, Schackert HK, Hoogerbrugge N, van Kessel AG, Ligtenberg MJ.
|
| Hum Mutat 32(4):407-14. doi: 10.1002/humu.21446. Epub 2011 Mar 1. 2011
|
| 2 | EPCAM
|
| Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity.
|
| Akita H, Nagano H, Takeda Y, Eguchi H, Wada H, Kobayashi S, Marubashi S, Tanemura M, Takahashi H, Ohigashi H, Tomita Y, Ishikawa O, Mori M, Doki Y.
|
| Oncogene 30(31):3468-76. doi: 10.1038/onc.2011.59. Epub 2011 Mar 14.
2011
|
| 3 | CLDN7, EPCAM
|
| Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming.
|
| Huang HP, Chen PH, Yu CY, Chuang CY, Stone L, Hsiao WC, Li CL, Tsai SC, Chen KY, Chen HF, Ho HN, Kuo HC.
|
| J Biol Chem 286(38):33520-32. Epub 2011 Jul 28.
2011
|
| 4 | EPCAM, HNPCC1
|
| Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome.
|
| Kovacs ME, Papp J, Szentirmay Z, Otto S, Olah E.
|
| Hum Mutat 30(2):197-203. 2009
|
| 5 | EPCAM, HNPCC
|
| Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.
|
| Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, Lee TY, Bodmer D, Hoenselaar E, Hendriks-Cornelissen SJ, Tsui WY, Kong CK, Brunner HG, van Kessel AG, Yuen ST, van Krieken JH, Leung SY, Hoogerbrugge N.
|
| Nat Genet 41(1):112-7. Epub 2008 Dec 21. 2009
|
| 6 | DIAR5, EPCAM
|
| Tufting enteropathy and chronic arthritis: a newly recognized association with a novel EpCAM gene mutation.
|
| Al-Mayouf SM, Alswaied N, Alkuraya FS, Almehaidib A, Faqih M.
|
| J Pediatr Gastroenterol Nutr 49(5):642-4. No abstract available. PMID: 19820410 2009
|
| 7 | EPCAM
|
| The emerging role of EpCAM in cancer and stem cell signaling.
|
| Munz M, Baeuerle PA, Gires O.
|
| Cancer Res 69(14):5627-9. Epub 2009 Jul 7. Review.PMID: 19584271 2009
|
| 8 | EPCAM, MLH1
|
| Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.
|
| Niessen RC, Hofstra RM, Westers H, Ligtenberg MJ, Kooi K, Jager PO, de Groote ML, Dijkhuizen T, Olderode-Berends MJ, Hollema H, Kleibeuker JH, Sijmons RH.
|
| Genes Chromosomes Cancer 48(8):737-44.PMID: 19455606 2009
|
| 9 | EPCAM
|
| EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer.
|
| Wenqi D, Li W, Shanshan C, Bei C, Yafei Z, Feihu B, Jie L, Daiming F.
|
| J Cancer Res Clin Oncol 135(9):1277-85. Epub 2009 Mar 18.PMID: 19294417 2009
|
| 10 | DIAR5, EPCAM
|
| Identification of EpCAM as the gene for congenital tufting enteropathy.
|
| Sivagnanam M, Mueller JL, Lee H, Chen Z, Nelson SF, Turner D, Zlotkin SH, Pencharz PB, Ngan BY, Libiger O, Schork NJ, Lavine JE, Taylor S, Newbury RO, Kolodner RD, Hoffman HM.
|
| Gastroenterology 135(2):429-37. Epub 2008 May 15.PMID: 18572020 [PubMed 2008
|
| 11 | EPCAM
|
| Prognostic significance of EpCAM expression in human esophageal cancer.
|
| Kimura H, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y, Miyazaki T, Masuda N, Fukuchi M, Kuwano H.
|
| Int J Oncol 30(1):171-9. 2007
|
| 12 | EPCAM, GDLD, TACSTD2
|
| Phenotypic investigation of cell junction-related proteins in gelatinous drop-like corneal dystrophy.
|
| Takaoka M, Nakamura T, Ban Y, Kinoshita S.
|
| Invest Ophthalmol Vis Sci 48(3):1095-101. 2007
|
| 13 | EPCAM
|
| The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7.
|
| Ladwein M, Pape UF, Schmidt DS, Schnolzer M, Fiedler S, Langbein L, Franke WW, Moldenhauer G, Zoller M.
|
| Exp Cell Res 309(2):345-57. 2005
|
| 14 | EPCAM
|
| EpCAM expression in retinoblastoma: a novel molecular target for therapy.
|
| Krishnakumar S, Mohan A, Mallikarjuna K, Venkatesan N, Biswas J, Shanmugam MP, Ren-Heidenreich L.
|
| Invest Ophthalmol Vis Sci 45(12):4247-50. 2004
|
| 15 | EPCAM
|
| The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation.
|
| Munz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O.
|
| Oncogene 23(34):5748-58. 2004
|
| 16 | EPCAM
|
| Cloning and characterisation of a 1.1 kb fragment of the carcinoma-associated epithelial cell adhesion molecule promoter.
|
| Gires O, Eskofier S, Lang S, Zeidler R, Munz M.
|
| Anticancer Res 23(4):3255-61. 2003
|
| 17 | EPCAM, TACSTD2
|
| Retroposition in a family of carcinoma-associated antigen genes.
|
| Linnenbach AJ, et al.
|
| Mol Cell Biol 13 : 1507-1515. 1993
|
| 18 | EPCAM
|
| Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2.
|
| Szala S, et al.
|
| Proc Natl Acad Sci U S A 87 : 3542-3546. 1990
|
| 19 | EPCAM, TACSTD2
|
| Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733.
|
| Linnenbach AJ, et al.
|
| Proc Natl Acad Sci U S A 86(1):27-31. 1989
|
| 20 | EPCAM
|
| Characterization and chromosomal assignment of a human cell surface antigen defined by the monoclonal antiboby AUAI.
|
| Spurr NK, et al.
|
| Int J Cancer 38 : 631-636. 1986
|